About: Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease; as well as DMX-652 for the treatment of acute kidney injury. The company is headquartered in Fitzroy, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.19 (-2.63%)
DXB ASX Dimerix Ltd
Dimerix Ltd share price
Atividade de preço de DXB
Último preço
$ 0,190
Variação (24h)
-0,01 AUD (2,63%)
Volume
559.77K
Volume (média 4 sem.)
-
Abertura
$ 0,19
Variação do dia
$ 0,18 - $ 0,19
Fechamento anterior
$ 0,19
Último negócio
20 Nov, 5:10 am GMT+0
Atrasado
20 Nov, 5:10 am GMT+0
DXB price performance
Atrasado
20 Nov, 5:10 am GMT+0
DXB details
quote.marketSignals